Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
JAMA Intern Med. 2013 Jul 22;173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056.
Clostridium difficile infection (CDI) has been increasingly reported among healthy individuals in the community. Recent data suggest that community-associated CDI represents one-third of all C difficile cases. The epidemiology and potential sources of C difficile in the community are not fully understood.
To determine epidemiological and clinical characteristics of community-associated CDI and to explore potential sources of C difficile acquisition in the community.
Active population-based and laboratory-based CDI surveillance in 8 US states.
Medical records were reviewed and interviews performed to assess outpatient, household, and food exposures among patients with community-associated CDI (ie, toxin or molecular assay positive for C difficile and no overnight stay in a health care facility within 12 weeks). Molecular characterization of C difficile isolates was performed. Outpatient health care exposure in the prior 12 weeks among patients with community-associated CDI was a priori categorized into the following 3 levels: no exposure, low-level exposure (ie, outpatient visit with physician or dentist), or high-level exposure (ie, surgery, dialysis, emergency or urgent care visit, inpatient care with no overnight stay, or health care personnel with direct patient care).
Prevalence of outpatient health care exposure among patients with community-associated CDI and identification of potential sources of C difficile by level of outpatient health care exposure.
Of 984 patients with community-associated CDI, 353 (35.9%) did not receive antibiotics, 177 (18.0%) had no outpatient health care exposure, and 400 (40.7%) had low-level outpatient health care exposure. Thirty-one percent of patients without antibiotic exposure received proton pump inhibitors. Patients having CDI with no or low-level outpatient health care exposure were more likely to be exposed to infants younger than 1 year (P = .04) and to household members with active CDI (P = .05) compared with those having high-level outpatient health care exposure. No association between food exposure or animal exposure and level of outpatient health care exposure was observed. North American pulsed-field gel electrophoresis (NAP) 1 was the most common (21.7%) strain isolated; NAP7 and NAP8 were uncommon (6.7%).
Most patients with community-associated CDI had recent outpatient health care exposure, and up to 36% would not be prevented by reduction of antibiotic use only. Our data support evaluation of additional strategies, including further examination of C difficile transmission in outpatient and household settings and reduction of proton pump inhibitor use.
艰难梭菌感染(CDI)在社区中的健康人群中越来越多地被报道。最近的数据表明,社区相关的 CDI 占所有艰难梭菌病例的三分之一。社区中艰难梭菌的流行病学和潜在来源尚不完全清楚。
确定社区相关 CDI 的流行病学和临床特征,并探讨社区中获得艰难梭菌的潜在来源。
在美国 8 个州进行的主动人群和基于实验室的 CDI 监测。
对门诊、家庭和食物暴露情况进行了医疗记录回顾和访谈,以评估患有社区相关 CDI 的患者(即毒素或分子检测阳性的艰难梭菌,且在 12 周内无在医疗机构过夜)。对艰难梭菌分离株进行了分子特征分析。在患有社区相关 CDI 的患者中,在过去 12 周内的门诊医疗暴露情况被预先分为以下 3 个级别:无暴露、低水平暴露(即门诊就诊于医生或牙医)或高水平暴露(即手术、透析、急诊或紧急护理就诊、无过夜住院治疗或直接接触患者的医护人员)。
社区相关 CDI 患者门诊医疗暴露的发生率,以及根据门诊医疗暴露水平确定艰难梭菌的潜在来源。
在 984 例社区相关 CDI 患者中,353 例(35.9%)未接受抗生素治疗,177 例(18.0%)无门诊医疗暴露,400 例(40.7%)有低水平的门诊医疗暴露。31%未接受抗生素治疗的患者接受了质子泵抑制剂治疗。无或低水平门诊医疗暴露的 CDI 患者更有可能接触到 1 岁以下的婴儿(P =.04)和有活动期 CDI 的家庭成员(P =.05),而与高水平门诊医疗暴露的患者相比。未观察到食物暴露或动物暴露与门诊医疗暴露水平之间存在关联。北美脉冲场凝胶电泳(NAP)1 是最常见的(21.7%)分离株;NAP7 和 NAP8 则不常见(6.7%)。
大多数社区相关 CDI 患者最近有门诊医疗暴露,仅通过减少抗生素的使用,多达 36%的患者仍无法预防。我们的数据支持评估其他策略,包括进一步研究门诊和家庭环境中艰难梭菌的传播以及减少质子泵抑制剂的使用。